149 results on '"López‐Labrador, F. Xavier"'
Search Results
2. Air quality of health facilities in Spain
3. Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics
4. New developments in the management of hepatitis C virus infection : focus on boceprevir
5. Clinical and phylogenetic influenza dynamics for the 2019-20 season in the global influenza hospital surveillance network (GIHSN) – Pilot study
6. Enterovirus D68 disease burden and epidemiology in hospital‐admitted influenza‐like illness, Valencia region of Spain, 2014–2020 influenza seasons.
7. Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples
8. Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting
9. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
10. Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
11. Development of Photonic Multi-Sensing Systems Based on Molecular Gates Biorecognition and Plasmonic Sensors: The PHOTONGATE Project
12. Indoor Air Quality and Bioaerosols in Spanish University Classrooms.
13. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.
14. Development of Photonic Multi-Sensing Systems Based on Molecular Gates Biorecognition and Plasmonic Sensors: The PHOTONGATE Project
15. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
16. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe
17. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season
18. In vivo effect of mouthwashes on viable viral load of SARS-CoV-2 in saliva: a pilot study
19. Quantitative Analysis of Hepatitis C Virus-Specific CD8+ T Cells in Peripheral Blood and Liver Using Peptide-MHC Tetramers
20. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial
21. WED-009 Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
22. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation
23. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
24. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
25. Retrospective screening for SARS‐CoV‐2 among influenza‐like illness hospitalizations: 2018–2019 and 2019–2020 seasons, Valencia region, Spain
26. Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
27. Whole-Genome Analysis Surveillance of Influenza A Virus Resistance to Polymerase Complex Inhibitors in Eastern Spain from 2016 to 2019
28. Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season
29. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
30. Role of age and birth month in infants hospitalized with RSV‐confirmed disease in the Valencia Region, Spain.
31. Retrospective screening for SARS‐CoV‐2 among influenza‐like illness hospitalizations: 2018–2019 and 2019–2020 seasons, Valencia region, Spain.
32. A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area
33. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosis
34. Is PD-1 blockade a potential therapy for HBV?
35. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study
36. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season
37. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014
38. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.
39. No substantial circulation of enterovirus D68 in patients with severe respiratory disease in South-eastern Spain (Valencian Community) during the 2015–2016 influenza season
40. Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6
41. Overcoming drug resistance in HSV, CMV, HBV and HCV infection
42. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
43. Hospital Admissions Associated to Respiratory Viruses, 2014–2015 Season: Valencia Hospital Network for the Study of Influenza and Other Respiratory Viruses (Spain)
44. Influenza Vaccine Effectiveness in Preventing Admissions With Influenza During the 2014-2015 Influenza Season: A Test-Negative Hospital-Based Study, in the Valencia Hospital Network for the Study of Influenza and Respiratory Viruses Disease, Valencia (Spain)
45. Computational models of liver fibrosis progression for hepatitis C virus chronic infection
46. Resumen de congreso: 20 años después del primer Simposium Internacional sobre el virus de la hepatitis C y otros virus relacionados
47. Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients
48. Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes
49. Recombination in Hepatitis C Virus
50. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.